Aphena Pharma Solutions Welcomes New Director of Business Development

Aphena logo

COOKEVILLE, Tenn. — Addison Galyon recently joined the Aphena Pharma Solutions commercial sales team as a director of business development.

Galyon comes to Aphena from Jabil Healthcare, where, as business unit manager, he was responsible for Nypro’s fastest growing healthcare diagnostics plant, with year-over-year revenue growth of 15%.

Prior to that, he served as the director of project management for PCI Pharma Solutions, where he was responsible for PCI’s largest business unit, with sales revenue of $60 million per year across 13 pharmaceutical clients, including several of the top 10 pharmaceutical companies in the world.

Galyon earned his Bachelor of Science in packaging and his MBA from Rockford University in Rockford, Illinois.

“Given Addison’s extensive experience in equipment and process qualification, forecast and demand management, and process improvement leadership with a continuous improvement mindset, he is well qualified to take Aphena to the next level in giving our clients the best possible experience,” said Aphena EVP of Sales Eric Allen.

Aphena Pharma Solutions is an industry-leading organization providing contract manufacturing and packaging for the pharmaceutical, consumer health, biologics and medical device markets. With two separate FDA- and DEA-registered locations in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotion-based products.

Aphena meets and exceeds FDA standards for 21 CFR, Parts 111, 210, 211 and 820, and is DEA (CII-V) licensed; cGMP compliant, ISO 13485:2016 and 9001:2015 (BSI); UL Certified; and USP verified.

For more information about Aphena, visit www.aphenapharma.com or call (931) 372-2041 or 1-866-465-4506.